H. Gregory, IR. Willshire, The isolation of the urogastrones - inhibitors of gastric acid secretion - from human urine., in Hoppe Seylers Z Physiol Chem, vol. 356, n. 11, Nov 1975, pp. 1765-74, PMID 1205452.
H. Gregory, S. Walsh; CR. Hopkins, The identification of urogastrone in serum, saliva, and gastric juice., in Gastroenterology, vol. 77, n. 2, Aug 1979, pp. 313-8, PMID 312747.
H. Gregory, BM. Preston, The primary structure of human urogastrone., in Int J Pept Protein Res, vol. 9, n. 2, 1977, pp. 107-18, PMID 300079.
LA. Scheving, Primary amino acid sequence similarity between human epidermal growth factor-urogastrone, human pancreatic secretory trypsin inhibitor, and members of porcine secretin family., in Arch Biochem Biophys, vol. 226, n. 2, Oct 1983, pp. 411-3, PMID 6605724.
JA. Walker-Smith, AD. Phillips; N. Walford; H. Gregory; JD. Fitzgerald; K. MacCullagh; NA. Wright, Intravenous epidermal growth factor/urogastrone increases small-intestinal cell proliferation in congenital microvillous atrophy., in Lancet, vol. 2, n. 8466, Nov 1985, pp. 1239-40, PMID 2866310.
B. Drumm, E. Cutz; KB. Tomkins; D. Cook; JR. Hamilton; P. Sherman, Urogastrone/epidermal growth factor in treatment of congenital microvillous atrophy., in Lancet, vol. 1, n. 8577, Jan 1988, pp. 111-2, PMID 2891946.
PB. Sullivan, MJ. Brueton; ZB. Tabara; RA. Goodlad; CY. Lee; NA. Wright, Epidermal growth factor in necrotising enteritis., in Lancet, vol. 338, n. 8758, Jul 1991, pp. 53-4, PMID 1676104.
AS. Tarnawski, MK. Jones, The role of epidermal growth factor (EGF) and its receptor in mucosal protection, adaptation to injury, and ulcer healing: involvement of EGF-R signal transduction pathways., in J Clin Gastroenterol, 27 Suppl 1, 1998, pp. S12-20, PMID 9872493.
P. Skov Olsen, SS. Poulsen; K. Therkelsen; E. Nexø, Oral administration of synthetic human urogastrone promotes healing of chronic duodenal ulcers in rats., in Gastroenterology, vol. 90, n. 4, Apr 1986, pp. 911-7, PMID 3485062.
A. RE, F. CADARIO, [Urogastrone principle in the treatment of gastroduodenal ulcer]., in Minerva Gastroenterol, vol. 3, n. 3-4, Dec 1957, pp. 116-9, PMID 13526585.
A. Miyoshi, M. Moriga; A. Moriya; K. Kokawa; H. Sugimoto, [New trends in the therapy of peptic ulcer--with special reference to urogastrone]., in Naika, vol. 19, n. 6, Jun 1967, pp. 1199-209, PMID 6079599.
JB. Elder, PC. Ganguli; IE. Gillepie; I. Delamore; H. Gregory, Proceedings: Effect of urogastrone in the Zollinger-Ellison syndrome., in Gut, vol. 15, n. 10, Oct 1974, p. 840, PMID 4611757.
JB. Elder, IE. Gillespie; PC. Ganguli; WI. Delamore; H. Gregory, Effect of urogastrone in the Zollinger-Ellison syndrome., in Lancet, vol. 2, n. 7932, Sep 1975, pp. 424-7, PMID 51236.
J. Stasiewicz, A. Janke; J. Moniuszko-Jakoniuk, [Urogastrone in the treatment of peptic ulcer: yes or no?]., in Pol Tyg Lek, vol. 41, n. 51-52, pp. 1646-9, PMID 3495791.
A. Guglietta, PB. Sullivan, Clinical applications of epidermal growth factor., in Eur J Gastroenterol Hepatol, vol. 7, n. 10, Oct 1995, pp. 945-50, PMID 8590139.
IK. Cohen, MC. Crossland; A. Garrett; RF. Diegelmann, Topical application of epidermal growth factor onto partial-thickness wounds in human volunteers does not enhance reepithelialization., in Plast Reconstr Surg, vol. 96, n. 2, Aug 1995, pp. 251-4, PMID 7624397.
X. Fu, Z. Shen; Y. Chen; J. Xie; Z. Guo; M. Zhang; Z. Sheng, Recombinant bovine basic fibroblast growth factor accelerates wound healing in patients with burns, donor sites and chronic dermal ulcers., in Chin Med J (Engl), vol. 113, n. 4, Apr 2000, pp. 367-71, PMID 11775238.
CG. Koffman, JB. Elder; PC. Ganguli; H. Gregory; CG. Geary, Effect of urogastrone on gastric secretion and serum gastrin concentration in patients with duodenal ulceration., in Gut, vol. 23, n. 11, Nov 1982, pp. 951-6, PMID 6813198.